The Children's Mercy oncology program is a national leader in cancer treatment. Our program provides children and teens with comprehensive clinical services and innovative treatment—including Phase I Experimental Therapeutics, stem cell transplantation, and immunotherapies such as CAR T-cell—supported by the latest research.
We provide advanced treatment for children with all types of cancer at our locations in Kansas City, Joplin and Springfield, Missouri. In Kansas City, we also offer a clinic for Spanish-speaking families with bilingual staff and resources.
Pediatric oncologists and specialists
Our care team includes more than 25 pediatric oncologists and hematology specialists. Dedicated nurse practitioners help coordinate each step of treatment. This includes chemotherapy, surgery, radiation, labs, and any other services children and families need from the time of diagnosis until care is completed. Our team creates a care plan suited to each child's individual treatment needs.
Designated by the National Institutes of Cancer
As the primary pediatric cancer provider and the only NCI Children’s Oncology Group institution in the Midwest Cancer Alliance, Children’s Mercy is the pediatric consortium partner for the National Cancer Institute-designated The University of Kansas Cancer Center and the Stowers Institute for Medical Research. This partnership offers progress in cutting-edge cancer research to help advance care for children with cancer.
The Division also has received accreditation from the Foundation for Accreditation of Cellular Therapy.